Psyence Biomedical (PBM) Change in Accured Expenses (2023 - 2025)

Psyence Biomedical's Change in Accured Expenses history runs 3 years deep, the most recent figure standing at $644700.0 for Q3 2025.

• In Q3 2025, Change in Accured Expenses fell 24.91% year-over-year to $644700.0; the TTM figure through Sep 2025 stood at $644700.0 (down 24.91% YoY), while the FY2025 annual figure was $394270.0, down 47.79% from the prior year.
• Change in Accured Expenses was $644700.0 for Q3 2025 at Psyence Biomedical, up from $394270.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q1 2023 to a low of $394270.0 in Q1 2025.
• Historically, Change in Accured Expenses has averaged $888686.0 across 3 years, with a median of $755202.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 57.83% in 2024, then decreased 24.91% in 2025.
• A 3-year view of Change in Accured Expenses shows it stood at $1.8 million in 2023, then sank by 52.05% to $858558.0 in 2024, then fell by 24.91% to $644700.0 in 2025.
• The last three Change in Accured Expenses figures came in at $644700.0 (Q3 2025), $394270.0 (Q1 2025), and $858558.0 (Q3 2024), per Business Quant data.